Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Gartanin
Cat. No.:
0225LY-1065
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Gartanin serves as an enhancer of androgen receptor degradation and acts as a neuroprotective agent against oxidative damage, likely by upregulating AMPK/SIRT1/PGC-1α and Nrf-2-independent HO-1 signaling.
Synonym:
33390-42-0; 1,3,5,8-Tetrahydroxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one; 9H-Xanthen-9-one, 1,3,5,8-tetrahydroxy-2,4-bis(3-methyl-2-butenyl)-; Gartinin; 1,3,5,8-tetrahydroxy-2,4-bis(3-methylbut-2-enyl)xanthen-9-one; 1,3,5,8-Tetrahydroxy-2,4-diprenylxanthone; 1,3,5,8-Tetrahydroxy-2,4-bis(3-methyl-2-butenyl)-9H-xanthen-9-one, 9CI; 1,3,5,8-Tetrahydroxy-2,4-bis(3-methyl-2-buten-1-yl)-9H-xanthen-9-one
CAS No.:
33390-42-0
Compound CID:
5281633
Formula:
C23H24O6
Formula Weight:
396.43
Specification
Relative Density:
1.326 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Gartanin can be used in cancer research to examine the induction of autophagy and apoptosis through the modulation of MAPK signaling.
Library Information
Target:
JNK; Caspase; BCL
Receptor:
Bcl-2; Caspase; JNK
Pathways:
Proteases/Proteasome; Apoptosis; MAPK
Plate Number:
AOCL-14
Plate Location:
f10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 126.13 mM
